2012 American College of Rheumatology guidelines for management of gout. Part 2: Therapy and antiinflammatory prophylaxis of acute gouty arthritis

Patients with gout adhere to curative treatment if informed appropriately: proof-of-concept observational study

(2012) Frances Rees et al.   ANNALS OF THE RHEUMATIC DISEASES

Rilonacept (Interleukin-1 Trap) in the prevention of acute gout flares during initiation of urate-lowering therapy: Results of a phase II randomized, double-blind, placebo-controlled trial

(2012) H. Ralph Schumacher et al.   ARTHRITIS AND RHEUMATISM

Efficacy and Tolerability of Celecoxib in the Treatment of Acute Gouty Arthritis: A Randomized Controlled Trial

(2012) H. R. SCHUMACHER et al.   JOURNAL OF RHEUMATOLOGY

2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis

(2012) Jasvinder A. Singh et al.   ARTHRITIS CARE & RESEARCH

2012 American College of Rheumatology guidelines for management of gout. Part 1: Systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia

(2012) Dinesh Khanna et al.   ARTHRITIS CARE & RESEARCH

Management of Gout in the Older Adult

(2011) Michelle A. Fravel et al.   American Journal Geriatric Pharmacotherapy

Prevalence of Contraindications and Prescription of Pharmacologic Therapies for Gout

(2011) Robert T. Keenan et al.   AMERICAN JOURNAL OF MEDICINE

Canakinumab reduces the risk of acute gouty arthritis flares during initiation of allopurinol treatment: results of a double-blind, randomised study

(2011) N. Schlesinger et al.   ANNALS OF THE RHEUMATIC DISEASES

Novel evidence-based colchicine dose-reduction algorithm to predict and prevent colchicine toxicity in the presence of cytochrome P450 3A4/P-glycoprotein inhibitors

(2011) Robert A. Terkeltaub et al.   ARTHRITIS AND RHEUMATISM

Prevalence of gout and hyperuricemia in the US general population: The National Health and Nutrition Examination Survey 2007-2008

(2011) Yanyan Zhu et al.   ARTHRITIS AND RHEUMATISM

Developing a provisional definition of flare in patients with established gout

(2011) Angelo L. Gaffo et al.   ARTHRITIS AND RHEUMATISM

Effect of Prophylaxis on Gout Flares After the Initiation of Urate-Lowering Therapy: Analysis of Data From Three Phase III Trials

(2011) Robert L. Wortmann et al.   CLINICAL THERAPEUTICS

Efficacy and Tolerability of Pegloticase for the Treatment of Chronic Gout in Patients Refractory to Conventional Treatment

(2011)   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Comorbidities in Patients with Gout

(2011) Naomi Ichikawa et al.   NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS

NSAID Use Selectively Increases the Risk of Non-Fatal Myocardial Infarction: A Systematic Review of Randomised Trials and Observational Studies

(2011) Luis Alberto García Rodríguez et al.   PLoS One

Nouveaux traitements de la goutte

(2011) Pascal Richette et al.   PRESSE MEDICALE

Canakinumab relieves symptoms of acute flares and improves health-related quality of life in patients with difficult-to-treat Gouty Arthritis by suppressing inflammation: results of a randomized, dose-ranging study

(2011) Naomi Schlesinger et al.   ARTHRITIS RESEARCH & THERAPY

High versus low dosing of oral colchicine for early acute gout flare: Twenty-four-hour outcome of the first multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison colchicine study

(2010) Robert A. Terkeltaub et al.   ARTHRITIS AND RHEUMATISM

Canakinumab for the treatment of acute flares in difficult-to-treat gouty arthritis: Results of a multicenter, phase II, dose-ranging study

(2010) Alexander So et al.   ARTHRITIS AND RHEUMATISM

Chronic gout: epidemiology, disease progression, treatment and disease burden

(2010) Richard A. Brook et al.   CURRENT MEDICAL RESEARCH AND OPINION

Oral Colchicine (Colcrys®)

(2010) Lily P.H. Yang   DRUGS

Update on gout: new therapeutic strategies and options

(2010) Robert Terkeltaub   Nature Reviews Rheumatology

Anakinra's Efficacy is Variable in Refractory Gout: Report of Ten Cases

(2010) Kun Chen et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis

(2010) Jennifer M. Grossman et al.   ARTHRITIS CARE & RESEARCH

The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial

(2010) Michael A Becker et al.   ARTHRITIS RESEARCH & THERAPY

Work productivity loss due to flares in patients with chronic gout refractory to conventional therapy

(2010) N.L. Edwards et al.   JOURNAL OF MEDICAL ECONOMICS

Oral prednisolone is more cost-effective than oral indomethacin for treating patients with acute gout-like arthritis

(2009) Giles N. Cattermole et al.   European Journal of Emergency Medicine

Progress in Measurement Instruments for Acute and Chronic Gout Studies

(2009) R. GRAINGER et al.   JOURNAL OF RHEUMATOLOGY

Use of oral prednisolone or naproxen for the treatment of gout arthritis: a double-blind, randomised equivalence trial

(2008) Hein JEM Janssens et al.   LANCET

Determinants of the Clinical Outcomes of Gout During the First Year of Urate-Lowering Therapy

(2008) Michael A. Becker et al.   NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS

Comparison of Drug Adherence Rates Among Patients with Seven Different Medical Conditions

(2008) Becky A Briesacher et al.   PHARMACOTHERAPY